Company Filing History:
2 out of 192 
2 out of 8,684 
1 out of 3,539 
Years Active: 2007-2018
Title: Thomas C VanCott: Innovator in HIV Research
Introduction
Thomas C VanCott is a notable inventor based in Brookeville, MD (US). He has made significant contributions to the field of HIV research, holding 2 patents that focus on innovative methods and compositions related to HIV envelope proteins.
Latest Patents
VanCott's latest patents include "Truncated HIV envelope proteins (ENV), methods and compositions related thereto." This invention provides methods and related compositions pertaining to novel HIV envelope proteins. In some embodiments, the invention relates to methods and compositions for the preparation, production, and administration of isolated novel HIV envelope nucleic acid and protein sequences suitable, for example, as vaccines against HIV. Another significant patent is "MVA expressing modified HIV envelope, gag, and pol genes." This invention provides modified virus Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes.
Career Highlights
Throughout his career, VanCott has worked with esteemed organizations such as the Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. and the US Government as represented by the Secretary of the Army. His work has been pivotal in advancing research and development in the field of HIV.
Collaborations
VanCott has collaborated with notable individuals in his field, including Bernard Moss and Patricia L Earl. These collaborations have contributed to the success of his research and innovations.
Conclusion
Thomas C VanCott is a distinguished inventor whose work in HIV research has led to significant advancements in the field. His patents and collaborations reflect his commitment to improving healthcare through innovative solutions.